Home » Topics » Conferences

Conferences
RSS

Potent antiamnesia activity reported for AChE inhibitor DHED

Dec. 2, 1997

Anticonvulsant activity of retigabine established in preclinical model

Dec. 2, 1997

Takeda's PAF antagonist evaluated in preclinical model of asthma

Dec. 2, 1997

Phase I/II clinical trial of gene therapy for melanoma

Dec. 1, 1997

IL-2 gene therapy for metastatic solid tumors: phase I results

Dec. 1, 1997

New anesthetic agent in phase I at Synthelabo

Dec. 1, 1997

Dual-action compound YM-158 shows potential for asthma

Dec. 1, 1997

Preclinical results reported for Novartis' PDE IV inhibitor

Dec. 1, 1997

Esteve presents new calcium antagonists with potential as neuroprotectants

Dec. 1, 1997

New antiasthma compound reported at Japanese congress

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...